通过CDK1和CDK2的分子动态对CDK2抑制剂的选择性分析
Dmitrii O Shkil1, Anastasia S Fokina2, Dariy T Asainov1
1Moscow Institute of Physics and Technology, Institutskiy per. 9, Dolgoprudny, 141701, Russia.
Journal of molecular graphics & modelling
|January 12, 2026
概括
为乳腺癌开发选择性环素依赖激酶 (CDK) 抑制剂是一项挑战. 本研究确定了选择性向CDK1和CDK2的关键结构特征,帮助未来的药物设计.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 循环素依赖激酶 (CDKs) 对于细胞循环调节至关重要.
- CDKs是关键的治疗点,特别是在乳腺癌中.
- 选择性抑制CDK1和CDK2等密切相关的激酶是很困难的.
研究的目的:
- 确定选择性CDK1/CDK2抑制的结构和药理决定因素.
- 以指导下一代CDK抑制剂的设计,以改善治疗特征.
主要方法:
- 分子动力学模拟.分子动力学模拟.
- 蛋白质 - 配体相互作用分析.
- 已知抗CDK1和CDK2.2抑制剂的比较
主要成果:
- 确定了针对特定目标选择性的关键药理特征.
- 未发现的结构决定因素导致CDK1与CDK2的选择性抑制.
结论:
- 这些发现为设计更有选择性的CDK抑制剂提供了假设.
- 解决了对有效和向癌症治疗的需求.
相关概念视频
02:34Inhibition of Cdk Activity
5.5K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.5K
02:39Positive Regulator Molecules
6.5K
Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
6.5K
01:45Positive Regulator Molecules
134.1K
To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.
134.1K
02:15M-Cdk Drives Transition Into Mitosis
6.2K
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
6.2K
02:38S-Cdk Initiates DNA Replication
5.3K
The cell cycle is a series of events leading to DNA duplication followed by the division of cell content to form two daughter cells. The cell cycle progresses in four stages—the cell increases in size (gap 1 or G1-phase), duplicates its DNA (synthesis or S-phase), prepares to divide (gap 2 or G2-phase), and divides (mitosis or M-phase).
Two states at the origin of replication
In eukaryotes, the initiation of replication occurs at many sites on the chromosomes, called the origins of...
Two states at the origin of replication
In eukaryotes, the initiation of replication occurs at many sites on the chromosomes, called the origins of...
5.3K
00:50Anaphase Promoting Complex
3.3K
The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
3.3K